Oxular

oculex-pharmaceuticals

This company develops biodegradable intraocular implants and drug delivery systems to treat retinal diseases for patients with conditions such as macular oedema.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.

Graybug Vision

The company develops sustained-release injectable medicines for patients with retinal diseases and glaucoma to reduce the frequency of ocular treatments.

Re–Vana Therapeutics Ltd

Re-Vana Therapeutics develops sustained-release biodegradable implants for delivering drugs to the eye to treat patients with vision-threatening diseases such as macular degeneration.

GelMEDIX

GelMEDIX develops injectable hydrogel scaffolds and regenerative cell therapies to treat degenerative ocular diseases such as geographic atrophy for patients with vision loss.

Eyestem

The company develops cell replacement therapies to treat incurable blindness and retinal diseases for patients globally.

INEYE Therapeutics

This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.